New Zealand markets closed

Aurobindo Pharma Limited (AUROPHARMA.NS)

NSE - NSE Real-time price. Currency in INR
Add to watchlist
1,209.45+1.85 (+0.15%)
As of 01:40PM IST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
287,045,000
287,045,000
246,171,300
233,665,500
245,579,400
-
Cost of revenue
126,029,000
126,029,000
112,932,600
108,151,800
106,110,800
-
Gross profit
161,016,000
161,016,000
133,238,700
125,513,700
139,468,600
-
Operating expenses
Research development
-
-
395,100
652,400
688,100
1,217,900
Selling general and administrative
-
-
23,481,700
21,770,200
24,297,200
22,044,500
Total operating expenses
117,802,600
117,802,600
108,102,300
92,511,000
94,704,500
-
Operating income or loss
43,213,400
43,213,400
25,136,400
33,002,700
44,764,100
-
Interest expense
2,897,100
2,897,100
1,404,800
368,400
595,700
-
Income before tax
43,799,900
43,799,900
26,125,000
33,727,400
73,435,900
-
Income tax expense
12,110,200
12,110,200
6,848,500
7,256,300
20,097,700
-
Income from continuing operations
31,689,700
31,689,700
19,276,500
26,471,100
53,338,200
-
Net income
31,729,700
31,729,700
19,275,000
26,481,500
53,348,400
-
Net income available to common shareholders
31,729,700
31,729,700
19,275,000
26,481,500
53,348,300
-
Basic EPS
39.60
54.16
32.90
45.19
91.05
-
Diluted EPS
39.60
54.16
32.90
45.19
91.05
-
Basic average shares
587,116
585,851
585,866
585,939
585,939
-
Diluted average shares
587,116
585,851
585,866
585,939
585,939
-